Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference

NEXT STORY
Wright Medical Group N.V. Reports 2019 First Quarter Financial Results
PREV STORY
Aptose Reports Results for the First Quarter Ended March 31, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical Therapeutics

SALT LAKE CITY, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary ...

author_avatar
NASDAQ Market News

Ascendis Pharma Announces Two Posters on Rare Disease Pipeline Programs at ENDO 2018

- Baseline demographics of TransCon Growth Hormone phase 3 heiGHt Trial presented - - ...

author_avatar
NASDAQ Market News

Ultragenyx to Present at Leerink Partners Roundtable Series

NOVATO, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

author_avatar
NASDAQ Market News